Viewing Study NCT04167358


Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2026-02-03 @ 9:45 AM
Study NCT ID: NCT04167358
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-18
First Post: 2019-11-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Linerixibat Long-term Safety, and Tolerability Study
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module